Adriamycin versus adriamycin plus melphalan in advanced ovarian carcinoma.

Suppr

超能文献

作者信息

De Palo G M, De Lena M, Bonadonna G

出版信息

Cancer Treat Rep. 1977 May-Jun;61(3):355-7.

PMID:326402

Abstract

摘要

相似文献

Adriamycin versus adriamycin plus melphalan in advanced ovarian carcinoma.

Cancer Treat Rep. 1977 May-Jun;61(3):355-7.

Melphalan versus adriamycin in the treatment of advanced carcinoma of the ovary.

Surg Gynecol Obstet. 1975 Dec;141(6):899-902.

Controlled prospective trial of combination chemotherapy with cyclophosphamide, adriamycin, and 5-fluorouracil for the treatment of advanced ovarian cancer: a preliminary report.

Cancer Treat Rep. 1979 Feb;63(2):297-9.

Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.美法仑与顺铂联合化疗作为晚期卵巢癌初始治疗的随机试验：初步及长期结果——东部肿瘤协作组E2878研究

Cancer. 1996 Feb 15;77(4):733-42.

Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.晚期卵巢癌的化疗：基于随机试验的当前护理标准

Gynecol Oncol. 1994 Dec;55(3 Pt 2):S97-107. doi: 10.1006/gyno.1994.1347.

Preliminary report of a clinical trial of the treatment of patients with advanced stage III and IV ovarian cancer with melphalan, 5-fluorouracil, and methotrexate in combination and sequentially: a study of the Clinical Trials Group of the National Cancer Institute of Canada.

Cancer Treat Rep. 1979 Feb;63(2):289-95.

Advanced ovarian carcinoma: a pilot study of cis-dichlorodiammineplatinum(II) in combination with adriamycin and cyclophosphamide in previously untreated patients and as a single agent in previously treated patients.

Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1745-53.

Use of tissue culture in predictive testing of drug sensitivity in human ovarian cancer. Correlation between in vitro results and the response in vivo.

Neoplasma. 1982;29(3):309-14.

Melphalan with and without doxorubicin in advanced ovarian cancer.

Obstet Gynecol. 1987 Oct;70(4):582-6.

cis-Dichlorodiammineplatinum(II) and adriamycin treatment of advanced ovarian cancer.顺二氯二氨合铂（II）与阿霉素联合治疗晚期卵巢癌

Cancer Treat Rep. 1978 Dec;62(12):2027-30.

引用本文的文献

Endoscopic ultrasound-guided fine-needle aspiration pancreatic adenocarcinoma samples yield adequate DNA for next-generation sequencing: A cohort analysis.内镜超声引导下细针抽吸胰腺腺癌样本可提供足够的 DNA 用于下一代测序：一项队列分析。

World J Gastroenterol. 2023 May 14;29(18):2864-2874. doi: 10.3748/wjg.v29.i18.2864.

The cost implications of the use of pegylated liposomal doxorubicin when choosing an anthracycline for the treatment of platinum-resistant ovarian cancer: A low-value intervention?在为铂耐药卵巢癌选择蒽环类药物时使用聚乙二醇化脂质体阿霉素的成本影响：一种低价值干预措施？

Gynecol Oncol Rep. 2015 Jun 25;13:47-8. doi: 10.1016/j.gore.2015.06.009. eCollection 2015 Aug.

Chemotherapy for advanced ovarian cancer. Advanced Ovarian Cancer Trialists Group.晚期卵巢癌的化疗。晚期卵巢癌试验组。

Cochrane Database Syst Rev. 2000(2):CD001418. doi: 10.1002/14651858.CD001418.

Dose intensity analysis in advanced ovarian cancer patients.晚期卵巢癌患者的剂量强度分析。

Br J Cancer. 1993 Jan;67(1):190-7. doi: 10.1038/bjc.1993.33.

Prospective study with HEXA-CAF combination in ovarian carcinoma.

Cancer Chemother Pharmacol. 1981;5(3):157-61. doi: 10.1007/BF00258473.

Developing new drugs for ovarian cancer: a challenging task in a changing reality.开发卵巢癌新药：在不断变化的现实中的一项具有挑战性的任务。

J Cancer Res Clin Oncol. 1984;107(2):111-24. doi: 10.1007/BF00399382.

Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group.晚期卵巢癌的化疗：随机临床试验综述。晚期卵巢癌试验协作组

BMJ. 1991 Oct 12;303(6807):884-93. doi: 10.1136/bmj.303.6807.884.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验